Page last updated: 2024-08-25

brusatol and Hepatitis C

brusatol has been researched along with Hepatitis C in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, PS; Ebinuma, H; Fukasawa, M; Ikeda, M; Kanai, T; Kato, N; Koda, Y; Murakami, Y; Nakamoto, N; Ojiro, K; Saito, H; Saito, K; Saito, Y; Sugiyama, K; Suzuki, T; Taniki, N; Teratani, T1

Other Studies

1 other study(ies) available for brusatol and Hepatitis C

ArticleYear
Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells.
    BMC cancer, 2018, Jun-25, Volume: 18, Issue:1

    Topics: Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Hepatitis C; Humans; Liver Neoplasms; NF-E2-Related Factor 2; Quassins; RNA, Viral; Sorafenib; Transcriptome; Virus Replication

2018